Indicated for: prevention of urothelial toxicity
Route of administration: oral
Substance: mesna (antidote)
ATC: V03AF01 (Various | All other therapeutic products | Detoxifying agents for antineoplastic treatment)
Mesna is a medication used to protect against bladder toxicity caused by chemotherapy drugs such as cyclophosphamide and ifosfamide. It works by binding to toxic metabolites in the urine, preventing bladder damage.
The medication is administered orally or intravenously, as directed by a doctor, usually during chemotherapy. It is important for patients to follow the treatment regimen and consume adequate fluids to maintain proper diuresis.
Patients should be aware of potential side effects, such as nausea, vomiting, or allergic reactions. It is important to inform the doctor of any unusual symptoms.
Common side effects include nausea, vomiting, and diarrhea. In rare cases, severe reactions such as allergic reactions or skin rashes may occur. Patients should be informed of these risks before use.